혈액 튜브 세트 시장 : 유형, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Blood Tubing Set Market was valued at USD 921.34 million in 2023, expected to reach USD 973.24 million in 2024, and is projected to grow at a CAGR of 6.92%, to USD 1,472.34 million by 2030.

The blood tubing set market is pivotal in the medical sector, primarily facilitating the safe and efficient transfer of blood products during dialysis or blood transfusion. These sets are essential components connecting the patient to the dialysis machine or blood storage units, highlighting their necessity in maintaining blood purity and preventing contamination. They find application mainly in healthcare facilities such as hospitals, clinics, and specialized dialysis centers. The market's end-use scope involves primarily hospitals and clinics, along with home healthcare services, as more patients opt for at-home care solutions. Key growth factors impacting the market include the increasing prevalence of chronic kidney diseases, a growing aging population, and a rise in the number of dialysis patients globally. Additionally, technological advancements aiming at improving the efficacy and safety of blood tubing sets create significant opportunities for market players. However, stringent regulatory standards and the high cost associated with advanced tubing sets present challenges. The competition from alternative treatments, such as kidney transplants, also affects market growth. Despite these challenges, innovative opportunities exist in the development of eco-friendly and cost-effective tubing sets, incorporating smart technology that can monitor and control blood flow more accurately. Research could focus on enhancing biocompatibility and reducing the risk of infection, which would serve as a unique selling proposition in a competitive market. The global market is dynamic, characterized by regional variances in demand, driven by the availability of healthcare infrastructure and patient population demographics. To capitalize on potential opportunities, companies should invest in R&D aimed at fulfilling unmet needs and look towards strategic collaborations or acquisitions to enhance their market presence. This approach will help in navigating the challenges while driving sustainable growth in the blood tubing set market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Tubing Set Market

The Blood Tubing Set Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of chronic kidney diseases globally
  • Growing expansion and improvement of healthcare facilities
  • Increased awareness about kidney health and screening programs for early diagnosis
• Market Restraints
  • High costs associated with hemodialysis
• Market Opportunities
  • Rising government initiatives aimed at improving access to healthcare and managing chronic diseases
  • Increased government and private sector investments in healthcare infrastructure
• Market Challenges
  • Stringent regulatory requirements and logistical challenges

Porter's Five Forces: A Strategic Tool for Navigating the Blood Tubing Set Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Tubing Set Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Tubing Set Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Tubing Set Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Tubing Set Market

A detailed market share analysis in the Blood Tubing Set Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Tubing Set Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Tubing Set Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Tubing Set Market

A strategic analysis of the Blood Tubing Set Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Tubing Set Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International, Inc., Farmasol srl., Fresenius Kabi AG, Guangdong Biolight Meditech Co., Ltd., Haemonetics Corporation, Hindustan Syringes & Medical Devices Ltd, JMS Co., Ltd., Medical Components, Inc., Nikkiso Co.,, NIPRO CORPORATION, Perfect Medical Ind. Co., Ltd., Poly Medicure Limited, SB-Kawasumi Laboratories, Inc., Shandong Weigao Group Medical Polymer Co.,Ltd., Terumo Medical Corporation, Toray Medical Co., Ltd., Vogt Medical Vertrieb GmbH., and Weigao group.

Market Segmentation & Coverage

This research report categorizes the Blood Tubing Set Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Arterial Blood Tubing Sets and Venous Blood Tubing Sets.
• Based on Application, market is studied across Apheresis, Hemodialysis, Peritoneal Dialysis, and Plasmapheresis.
• Based on End User, market is studied across Ambulatory Surgical Centers, Blood Banks, Dialysis Centers, Home Healthcare, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of chronic kidney diseases globally
    • 5.1.1.2. Growing expansion and improvement of healthcare facilities
    • 5.1.1.3. Increased awareness about kidney health and screening programs for early diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with hemodialysis
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising government initiatives aimed at improving access to healthcare and managing chronic diseases
    • 5.1.3.2. Increased government and private sector investments in healthcare infrastructure
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements and logistical challenges
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing demand for venous blood tubing sets in hemodialysis and medical applications
  • 5.2.2. End-User: Expanding utilization of blood tubing sets across healthcare Settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Tubing Set Market, by Type

• 6.1. Introduction
• 6.2. Arterial Blood Tubing Sets
• 6.3. Venous Blood Tubing Sets

7. Blood Tubing Set Market, by Application

• 7.1. Introduction
• 7.2. Apheresis
• 7.3. Hemodialysis
• 7.4. Peritoneal Dialysis
• 7.5. Plasmapheresis

8. Blood Tubing Set Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Blood Banks
• 8.4. Dialysis Centers
• 8.5. Home Healthcare
• 8.6. Hospitals

9. Americas Blood Tubing Set Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Blood Tubing Set Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Blood Tubing Set Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Japanese medical firm Nipro plans first U.S. manufacturing plant in Greenville
  • 12.3.2. Haemonetics Corporation completes acquisition of Attune Medical
  • 12.3.3. CML Biotech installs world's first integrated blood collection tube manufacturing machine
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Asahi Kasei Medical Co., Ltd.
• 2. B. Braun SE
• 3. Baxter International, Inc.
• 4. Farmasol srl.
• 5. Fresenius Kabi AG
• 6. Guangdong Biolight Meditech Co., Ltd.
• 7. Haemonetics Corporation
• 8. Hindustan Syringes & Medical Devices Ltd
• 9. JMS Co., Ltd.
• 10. Medical Components, Inc.
• 11. Nikkiso Co.,
• 12. NIPRO CORPORATION
• 13. Perfect Medical Ind. Co., Ltd.
• 14. Poly Medicure Limited
• 15. SB-Kawasumi Laboratories, Inc.
• 16. Shandong Weigao Group Medical Polymer Co.,Ltd.
• 17. Terumo Medical Corporation
• 18. Toray Medical Co., Ltd.
• 19. Vogt Medical Vertrieb GmbH.
• 20. Weigao group